Heart valve fix may also shield kidneys in seniors

NCT ID NCT07464106

Recruiting now Disease control Sponsor: Robert Bosch Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a procedure to repair a leaky tricuspid heart valve can improve kidney function, reduce swelling, and boost physical activity in older adults. Researchers will follow 100 participants for changes in kidney health, walking ability, and daily function. The goal is to see if fixing the valve has benefits beyond the heart.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: transcatheter edge-to-edge repair (TEER) procedure
What this could lead to: If successful, this could show that fixing the tricuspid valve helps protect kidney function and improves mobility and daily living in older adults.
What could go wrong: This is an early observational study with only 100 participants, so results may not apply to everyone. The procedure itself carries risks like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIO-RENAL SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardio-renal syndrome Frailty tricuspid valve insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIO-RENAL SYNDROME FRAILTY TRICUSPID REGURGITATION TRICUSPID VALVE INSUFFICIENCY

Heart valve fix may also shield kidneys in seniors

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions